Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP) With or Without Opioids

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Addition of fentanyl or remifentanil to the propofol produced sedation for scheduled ERCP will decrease the propofol requirements for predetermined sedation levels (as shown by Bispectral Index Monitor (BIS) monitor), will be associated with faster recovery monitored by Ramsay's and Observer's Assessment of Alertness/Sedation (OAAS) scores and BIS, less postoperative pain (assessed by Visual Analogue Scale=VAS) and less early cognitive impairment after sedation (as assessed by the MiniMental test).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Athens
• Treatments: Fentanyl; Propofol; Remifentanil

Criteria

Inclusion Criteria:

• patients both sexes

• ASA I-III

• aged between 45 and 75 years old

• scheduled for interventional ERCP

Exclusion Criteria:

• patients receiving opioids or other analgesics, sedatives, hypnotics

• allergic to drugs used in the study protocol

• alcoholism

• refuse to sign the informed consent and chronic pain